ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CBDG THC Farmaceuticals Inc (PK)

0.043
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
THC Farmaceuticals Inc (PK) USOTC:CBDG OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.043 0.0142 0.052 0.00 21:00:00

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

29/11/2017 11:02am

Edgar (US Regulatory)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number:  000-54754

THC Farmaceuticals, Inc.
(Exact name of registrant as specified in its charter)

7170 E. McDonald Dr., Ste 3, Scottsdale, Arizona   85253, Tel: (480) 725-9060
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Common Stock
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

            Rule 12g-4(a)(1)            [X]
            Rule 12g-4(a)(2)            [  ]
            Rule 12h-3(b)(1)(i)        [  ]
            Rule 12h-3(b)(1)(ii)       [  ]
            Rule 15d-6                      [  ]
            Rule 15d-22(b)               [  ]

Approximate number of holders of record as of the certification or notice date:   65

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: November 28, 2017   By: /s/ Mike Gravel

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person.  The name and title of the person signing the form shall be typed or printed under the signature.

1 Year THC Farmaceuticals (PK) Chart

1 Year THC Farmaceuticals (PK) Chart

1 Month THC Farmaceuticals (PK) Chart

1 Month THC Farmaceuticals (PK) Chart

Your Recent History

Delayed Upgrade Clock